 bronchoalveolar lavag analysi wegen granulomatosi method diseas pathogenesi prospect analysi bronchoalveolar lavag bal patient wegen granulomatosi WG diseas control idiopath pulmonari fibrosi ipf normal control subject qualiti alveolar inflammatori respons activ WG determin antineutrophil cytoplasm antibodi anca present alveolar fluid lung patient WG determin inhal particl infecti agent etiolog role WG bal untreat activ WG mark increas neutrophil mean total wbc count eosinophil mean normal control subject neutrophil eosinophil untreat WG remiss neutrophil eosinophil diseas control ipf process neutrophil alveol popul neutrophil bal leukocyt remnant intact leukocyt bal macrophag patient WG ipf normal control subject normal subject control patient ipf neg anca serum anca serum bal patient activ WG diseas protein analysi bal disproportion increas igg ration serum valu igg index patient activ untreat diseas increas igg index igg anca reactiv pulmonari lymphoid tissu infecti agent bal techniqu studi